As of Oct. 1, 2026, the federal government’s new Controlled Substances Regulations (CSR) have come into effect. These regulations introduce changes to how health care practitioners, including Nurse Practitioners (NPs), prescribe, manage and handle controlled substances. All NPs are now required to follow the CSR.
Approved in late 2025, the CSR consolidates several existing regulations and brings together six class exemptions into a single, modernized regulation. It governs activities involving four categories of controlled substances— narcotics, controlled drugs, targeted substances (including benzodiazepines) and restricted drugs — across the health system, including for NPs.
“Oct. 1 represents the next step in strengthening patient safety and quality care when it comes to the use of controlled substances,” said Catriona Mill, Manager, Practice Quality at CNO. “It’s critical for NPs to understand these changes, as they will affect how NPs document, store and manage controlled substances in their day-to-day practice. Ensuring compliance is an important part of maintaining patient safety.”
What this will mean for NPs
- New safeguards and documentation requirements: NPs must now meet enhanced requirements for protective measures, record-keeping and reporting, including new obligations related to post-consumer returns (unused or expired controlled substances returned by patients).
- Expanded authority for returns and destruction: Under specific conditions, NPs are now authorized to destroy post-consumer returns of controlled substances and to sell or provide returned substances to a licensed dealer or the Minister.
- Authority to transport substances: Under specific conditions, the CSR authorizes NPs to send, deliver and transport controlled substances in accordance with the new regulation.
- Fewer prescribing restrictions: The regulation removes the previous restriction that prevented NPs from prescribing opium and coca leaves. Since these controlled substances are not marketed drugs, any authorized practitioner who wishes to prescribe them must apply for special access through the Health Canada Special Access Program.
CNO support and what’s next
CNO is committed to supporting NPs as they adopt the CSR into their practice. We have updated our Nurse Practitioner FAQs to help you understand what has changed, and we have also updated the Nurse Practitioner practice standard to align its section on controlled substances with the CSR.
If you have any additional questions about the CSR and how it affects NPs’ practice, please contact CNO’s Practice Support.